Form 4 for ZVRA ZEVRA THERAPEUTICS, INC.
Accepted 2021-08-30 00:00:00 ET · period of report 2021-08-30 · accession 0001437749-21-021199 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-30 | 2021-08-30 | ZVRA | Mickle Travis C | Pres, CEO, Dir | P - Purchase | $8.92 | +5,000 | 34.3K | +17% | +$44.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-30 | P | A | 5,000 | $8.92 | 34,271 | D | — | — |